The Role of Substance P in Ischaemic Brain Injury
AbstractStroke is a leading cause of death, disability and dementia worldwide. Despite extensive pre-clinical investigation, few therapeutic treatment options are available to patients, meaning that death, severe disability and the requirement for long-term rehabilitation are common outcomes. Cell loss and tissue injury following stroke occurs through a number of diverse secondary injury pathways, whose delayed nature provides an opportunity for pharmacological intervention. Amongst these secondary injury factors, increased blood-brain barrier permeability and cerebral oedema are well-documented complications of cerebral ischaemia, whose severity has been shown to be associated with final outcome. Whilst the mechanisms of increased blood-brain barrier permeability and cerebral oedema are largely unknown, recent evidence suggests that the neuropeptide substance P (SP) plays a central role. The aim of this review is to examine the role of SP in ischaemic stroke and report on the potential utility of NK1 tachykinin receptor antagonists as therapeutic agents. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Turner, R.J.; Vink, R. The Role of Substance P in Ischaemic Brain Injury. Brain Sci. 2013, 3, 123-142.
Turner RJ, Vink R. The Role of Substance P in Ischaemic Brain Injury. Brain Sciences. 2013; 3(1):123-142.Chicago/Turabian Style
Turner, Renée J.; Vink, Robert. 2013. "The Role of Substance P in Ischaemic Brain Injury." Brain Sci. 3, no. 1: 123-142.